Login to Your Account


No worries for Avanir
Eager investors drove shares of Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) to a 52-week high of $13.09 Monday after the company reported phase II data on AVP-923 to treat agitation in patients with Alzheimer's disease (AD). more »

Our Habitat for All Things Science
2014 Lasker Award again goes for therapeutic brain stimulation

Alim Louis Benabid and Mahlon R. DeLong are the recipients of the 2014 Lasker~DeBakey Clinical Medical Research Award "for Development of Deep Brain Stimulation of the Subthalamic Nucleus," a treatment for patients with Parkinson's disease who no longer respond to treatment with the drug L-dopa.

The Albert Lasker Basic Medical Research Award was shared by Kazutoshi Mori and Peter Walter for their discoveries about the unfolded protein response, a cellular quality control system.

READ MORE »

Opinion


Partners in Focus